US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist
  • 3.940
  • +0.040+1.03%
Close Jul 26 16:00 ET
  • 3.940
  • 0.0000.00%
Post 16:01 ET
167.23MMarket Cap-3581P/E (TTM)

Repare Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
822.93%52.4M
-61.21%51.13M
-28.31%13.05M
-98.08%2.16M
4,354.93%30.25M
1,291.67%5.68M
1,634.61%131.83M
164.62%18.2M
40,383.81%112.55M
143.37%679K
Operating revenue
822.93%52.4M
-61.21%51.13M
-28.31%13.05M
-98.08%2.16M
4,354.93%30.25M
1,291.67%5.68M
1,634.61%131.83M
164.62%18.2M
40,383.81%112.55M
143.37%679K
Cost of revenue
Gross profit
Operating expense
3.05%41.59M
10.37%167.36M
16.08%43.91M
3.66%40.58M
7.85%42.51M
14.54%40.36M
30.42%151.63M
6.23%37.83M
22.50%39.15M
46.27%39.41M
Selling and administrative expenses
1.04%8.62M
3.70%33.76M
8.93%8.65M
-0.46%7.87M
9.84%8.72M
-2.85%8.53M
24.21%32.56M
3.93%7.94M
19.83%7.9M
17.76%7.94M
-General and administrative expense
1.04%8.62M
3.70%33.76M
8.93%8.65M
-0.46%7.87M
9.84%8.72M
-2.85%8.53M
24.21%32.56M
3.93%7.94M
19.83%7.9M
17.76%7.94M
Research and development costs
3.58%32.97M
12.20%133.59M
17.98%35.27M
4.70%32.71M
7.35%33.79M
20.30%31.83M
32.23%119.07M
6.86%29.89M
23.19%31.24M
55.78%31.48M
Operating profit
131.19%10.82M
-487.11%-116.22M
-57.23%-30.87M
-152.34%-38.42M
68.35%-12.26M
0.42%-34.68M
81.78%-19.8M
31.68%-19.63M
331.70%73.4M
-45.25%-38.73M
Net non-operating interest income expense
-13.39%2.97M
136.80%13.33M
5.97%3.11M
63.39%3.31M
541.36%3.49M
2,556.59%3.43M
2,074.13%5.63M
2,718.27%2.93M
3,724.53%2.03M
1,331.58%544K
Non-operating interest income
-13.39%2.97M
136.80%13.33M
5.97%3.11M
63.39%3.31M
541.36%3.49M
2,556.59%3.43M
2,074.13%5.63M
2,718.27%2.93M
3,724.53%2.03M
1,331.58%544K
Other net income (expense)
109.86%7K
-209.06%-289K
-211.27%-79K
-180.90%-72K
-151.54%-67K
-184.00%-71K
243.24%265K
198.61%71K
242.31%89K
228.71%130K
Gain on sale of security
155.36%31K
-155.19%-170K
-156.90%-33K
-131.75%-40K
-129.08%-41K
-229.41%-56K
313.89%308K
211.54%58K
281.82%126K
250.00%141K
Other non- operating income (expenses)
-60.00%-24K
-176.74%-119K
-453.85%-46K
13.51%-32K
-136.36%-26K
-87.50%-15K
-4.88%-43K
165.00%13K
-428.57%-37K
-57.14%-11K
Income before tax
144.03%13.79M
-642.29%-103.18M
-67.41%-27.84M
-146.58%-35.18M
76.78%-8.84M
9.79%-31.33M
87.20%-13.9M
42.06%-16.63M
338.97%75.52M
-42.39%-38.06M
Income tax
-82.61%629K
-161.95%-9.38M
-98.74%190K
-30,283.33%-16.3M
9,324.24%3.11M
11,200.00%3.62M
1,002.68%15.15M
3,747.57%15.03M
107.63%54K
107.84%33K
Net income
137.67%13.16M
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
344.27%75.46M
-44.79%-38.09M
Net income continuous Operations
137.67%13.16M
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
344.27%75.46M
-44.79%-38.09M
Minority interest income
Net income attributable to the parent company
137.67%13.16M
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
344.27%75.46M
-44.79%-38.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
137.67%13.16M
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
344.27%75.46M
-44.79%-38.09M
Basic earnings per share
137.35%0.31
-223.19%-2.23
10.67%-0.67
-125.00%-0.45
69.23%-0.28
0.00%-0.83
75.62%-0.69
-7.14%-0.75
316.87%1.8
-28.17%-0.91
Diluted earnings per share
136.14%0.3
-223.19%-2.23
10.67%-0.67
-126.32%-0.45
69.23%-0.28
0.00%-0.83
75.62%-0.69
-7.14%-0.75
306.02%1.71
-28.17%-0.91
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 822.93%52.4M-61.21%51.13M-28.31%13.05M-98.08%2.16M4,354.93%30.25M1,291.67%5.68M1,634.61%131.83M164.62%18.2M40,383.81%112.55M143.37%679K
Operating revenue 822.93%52.4M-61.21%51.13M-28.31%13.05M-98.08%2.16M4,354.93%30.25M1,291.67%5.68M1,634.61%131.83M164.62%18.2M40,383.81%112.55M143.37%679K
Cost of revenue
Gross profit
Operating expense 3.05%41.59M10.37%167.36M16.08%43.91M3.66%40.58M7.85%42.51M14.54%40.36M30.42%151.63M6.23%37.83M22.50%39.15M46.27%39.41M
Selling and administrative expenses 1.04%8.62M3.70%33.76M8.93%8.65M-0.46%7.87M9.84%8.72M-2.85%8.53M24.21%32.56M3.93%7.94M19.83%7.9M17.76%7.94M
-General and administrative expense 1.04%8.62M3.70%33.76M8.93%8.65M-0.46%7.87M9.84%8.72M-2.85%8.53M24.21%32.56M3.93%7.94M19.83%7.9M17.76%7.94M
Research and development costs 3.58%32.97M12.20%133.59M17.98%35.27M4.70%32.71M7.35%33.79M20.30%31.83M32.23%119.07M6.86%29.89M23.19%31.24M55.78%31.48M
Operating profit 131.19%10.82M-487.11%-116.22M-57.23%-30.87M-152.34%-38.42M68.35%-12.26M0.42%-34.68M81.78%-19.8M31.68%-19.63M331.70%73.4M-45.25%-38.73M
Net non-operating interest income expense -13.39%2.97M136.80%13.33M5.97%3.11M63.39%3.31M541.36%3.49M2,556.59%3.43M2,074.13%5.63M2,718.27%2.93M3,724.53%2.03M1,331.58%544K
Non-operating interest income -13.39%2.97M136.80%13.33M5.97%3.11M63.39%3.31M541.36%3.49M2,556.59%3.43M2,074.13%5.63M2,718.27%2.93M3,724.53%2.03M1,331.58%544K
Other net income (expense) 109.86%7K-209.06%-289K-211.27%-79K-180.90%-72K-151.54%-67K-184.00%-71K243.24%265K198.61%71K242.31%89K228.71%130K
Gain on sale of security 155.36%31K-155.19%-170K-156.90%-33K-131.75%-40K-129.08%-41K-229.41%-56K313.89%308K211.54%58K281.82%126K250.00%141K
Other non- operating income (expenses) -60.00%-24K-176.74%-119K-453.85%-46K13.51%-32K-136.36%-26K-87.50%-15K-4.88%-43K165.00%13K-428.57%-37K-57.14%-11K
Income before tax 144.03%13.79M-642.29%-103.18M-67.41%-27.84M-146.58%-35.18M76.78%-8.84M9.79%-31.33M87.20%-13.9M42.06%-16.63M338.97%75.52M-42.39%-38.06M
Income tax -82.61%629K-161.95%-9.38M-98.74%190K-30,283.33%-16.3M9,324.24%3.11M11,200.00%3.62M1,002.68%15.15M3,747.57%15.03M107.63%54K107.84%33K
Net income 137.67%13.16M-222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M344.27%75.46M-44.79%-38.09M
Net income continuous Operations 137.67%13.16M-222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M344.27%75.46M-44.79%-38.09M
Minority interest income
Net income attributable to the parent company 137.67%13.16M-222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M344.27%75.46M-44.79%-38.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 137.67%13.16M-222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M344.27%75.46M-44.79%-38.09M
Basic earnings per share 137.35%0.31-223.19%-2.2310.67%-0.67-125.00%-0.4569.23%-0.280.00%-0.8375.62%-0.69-7.14%-0.75316.87%1.8-28.17%-0.91
Diluted earnings per share 136.14%0.3-223.19%-2.2310.67%-0.67-126.32%-0.4569.23%-0.280.00%-0.8375.62%-0.69-7.14%-0.75306.02%1.71-28.17%-0.91
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg